Literature DB >> 28359764

Neuroimmunological response in neuro-Behçet's.

Alexis Alejandro Garcia-Rivero1, Javier Gonzalez-Argote2, José Pedro Martínez Larrarte3, Ivonne Margarita Iglesias González3, Alberto Juan Dorta-Contreras3.   

Abstract

Behçet's disease is a chronic, multisystem, autoimmune vasculitis characterized by a triad of key signs. We report the case of a 16-year-old Caucasian girl, who complained of headache, dizziness and paresis of the left side of her body. After physical examination and ancillary tests, she was diagnosed with Behçet's disease with neurological manifestations (neuro-Behçet's disease). She had a good response to treatment. IgG, IgA, IgM and albumin were quantified in serum and cerebrospinal fluid by single radial immunodiffusion. Intrathecal synthesis was found for the 3 classes of immunoglobulins. This is the first case in which the Reibergram was used to evaluate the neuroimmunological response in a patient with Behçet's disease, suggesting the use of this diagnostic means for the active phase of the disease.
Copyright © 2017 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Entities:  

Keywords:  Barrera sangre-líquido cefalorraquídeo; Behçet's disease; Blood-cerebrospinal fluid barrier; Enfermedad de Behçet; Immunoglobulins; Inmunoglobulinas; Intrathecal synthesis; Neuro-Behçet's disease; Neurobeçhet; Reibergram; Reibergrama; Síntesis intratecal

Mesh:

Year:  2017        PMID: 28359764     DOI: 10.1016/j.reuma.2017.02.005

Source DB:  PubMed          Journal:  Reumatol Clin (Engl Ed)        ISSN: 2173-5743


  1 in total

1.  Auto-immunity profile evaluation during different clinical manifestations of Behçet disease in Algerian patients: effect of corticosteroid treatment.

Authors:  Fatmazohra Djaballah-Ider; Abdelhamid Djaballah; Zineb Djeraba; Samia Chaib; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2019-02-05       Impact factor: 4.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.